Article Versions Notes

Huang C-Y, Hsu L-H, Chen C-Y, Chang G-C, Chang H-W, Hung Y-M, Liu K-J, Kao S-H. Inhibition of Alternative Cancer Cell Metabolism of EGFR Mutated Non-Small Cell Lung Cancer Serves as a Potential Therapeutic Strategy. Cancers. 2020; 12(1):181. https://doi.org/10.3390/cancers12010181

Huang, Chung-Yu, Li-Han Hsu, Chung-Yeh Chen, Gee-Chen Chang, Hui-Wen Chang, Yi-Mei Hung, Ko-Jiunn Liu, and Shu-Huei Kao. 2020. "Inhibition of Alternative Cancer Cell Metabolism of EGFR Mutated Non-Small Cell Lung Cancer Serves as a Potential Therapeutic Strategy" Cancers 12, no. 1: 181. https://doi.org/10.3390/cancers12010181

Huang, C.-Y., Hsu, L.-H., Chen, C.-Y., Chang, G.-C., Chang, H.-W., Hung, Y.-M., Liu, K.-J., & Kao, S.-H. (2020). Inhibition of Alternative Cancer Cell Metabolism of EGFR Mutated Non-Small Cell Lung Cancer Serves as a Potential Therapeutic Strategy. Cancers, 12(1), 181. https://doi.org/10.3390/cancers12010181